S.-R. C. Paola, “Clinical Response to Osimertinib Compared to Other Tyrosine Kinase Inhibitors and Chemotherapy in Non-Small Cell Lung Cancer”, acmcr, vol. 4, no. 6, pp. 1108–1115, Nov. 2020.